KHB Shanghai Kehua Bio-Engineering Acquires the Italian Technogenetics KHB Shanghai Kehua Bio-Engineering (PRNewsFoto/KHB) (PRNewsFoto/KHB) NEWS PROVIDED BY KHB Shanghai Kehua Bio-Engineering and Technogenetics Dec 21, 2015, 09:00 EST
MILAN, December 21, 2015 /PRNewswire/ --
KHB Shanghai Kehua Bio-Engineering Co., Ltd listed on the Shenzhen Stock Exchange (Stock Code 002022), one of the leading in vitro diagnostic (IVD) products developers in China, announced today the closure of the deal with
[b? Technogenetics, [/b?innovative immunodiagnostics Italian company, that concerns the acquisition of the Italian company and of the IVD assets of Altergon Italia, a manufacturing and innovative pharmaceutical formulations developer.......
Sure didn't start any run on our joy juice this morning.
I presume an increase of these kinda PRs now the added value has been proven in multitude. I say: buckle up for a, probably bumpy and too much time taking ride up.